DNAPrint Genomics, Inc. (DNAG)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (900.00%)
Jul 31, 2025, 8:00 PM EDT
Verve Therapeutics Market Cap
DNAPrint Genomics has a market cap or net worth of $1.30 thousand as of August 5, 2025. Its market cap has decreased by -99.80% in one year.
Market Cap
1.30K
Enterprise Value
n/a
Revenue
1.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 11, 1996, DNAPrint Genomics's market cap has decreased from 12.11M to 1.30K, a decrease of -99.99%. That is a compound annual growth rate of -27.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2025 | 1.30K | - |
| Dec 13, 2024 | 1.30K | - |
| Dec 28, 2023 | 1.30K | - |
| Dec 30, 2022 | 1.30K | - |
| Dec 31, 2021 | 1.30K | -99.00% |
| Dec 31, 2020 | 129.48K | 100.86% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| Glass House Brands | 438.99M |
| American Oncology Network | 408.39M |
| Northwest Biotherapeutics | 376.73M |